UnitedHealth Group Inc vs Unum Group Common Stock — how do they compare? UnitedHealth Group Inc trades at $396.5 (market cap $339.08B), while Unum Group Common Stock trades at $91.42 (market cap $14.57B). The key difference: UnitedHealth Group Inc is far larger — about 23.3× Unum Group Common Stock's market cap, and UnitedHealth Group Inc pays the higher dividend (2.46%). Which is the better fit depends on your goals — on Pluang, investors hold UnitedHealth Group Inc for 98 Days and Unum Group Common Stock for 0 Days on average.
| UNH | UNM | |
|---|---|---|
Market Cap | $339.08B | $14.57B |
Volume | 12,648,635 | 1,461,588 |
Sector | Health | Financials |
52-Week High | $436.35 | $96.57 |
52-Week Low | $259.02 | $70.66 |
Typical Hold Time | 98 Days | 0 Days |
Enterprise Value | $380.94B | $18.14B |
Dividend Yield | 2.46% | 2.19% |
Signals from Pluang's Aura AI — not financial advice
UnitedHealth Group (UNH) trades at $378.52, down 0.21% on the day, with strong technical momentum showing a bullish moving average signal. The company demonstrates robust fundamentals with consistent earnings beats in recent quarters, including Q3 2026 EPS of $4.69 beating expectations of $4.14. Revenue growth remains solid at $447.57B for 2025, though net margins have compressed to 3.14%. Recent developments include strategic moves with TPG for WellMed operations and continued AI investments in Optum Insight.
UNH presents a compelling investment case with 82.7% analyst buy ratings and a $470.11 consensus price target representing 24% upside. The company's Medicare Advantage strength and Optum improvements support growth, though regulatory scrutiny and medical cost pressures remain key risks. Strong institutional ownership and Michael Burry's recent call option position signal confidence in the turnaround story.
Unum Group (UNM) trades at $92.05, down 0.5% with neutral technical signals. The stock shows mixed earnings performance with Q1 2026 beating estimates but Q4 2025 and Q2 2026 missing expectations. Analyst consensus is positive with 50% buy ratings and a $101 price target representing 9.7% upside. The company maintains stable profitability with 5.31% net margin and recently announced a $1 billion share repurchase program to enhance shareholder returns.
UNM presents a balanced investment case with strong institutional support and shareholder-friendly capital returns, though earnings consistency remains a concern. The stock trades at reasonable valuations (P/E 21.36, P/S 1.15) with potential upside to analyst targets. Key risks include premium growth sustainability and claims experience volatility in the insurance operations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →Unum Group provides workplace benefits, including disability, life, accident, critical illness, dental, and vision insurance, along with leave management services. It serves employers through its Unum US, Unum International, and Colonial Life segments, distributing coverage via brokers and independent agents.
Read more on UNM →